Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-01-28

Clinical Trial Update: Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance

View source ↗

Summary

Clinical trial update exploring the optimal antiplatelet regimen for endovascular therapy in ischemic cerebrovascular disease with focus on clopidogrel resistan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Zhongrong Miao | Conditions: Ischemic Cerebrovascular Disease | Status: UNKNOWN